Lataa...
Financial Burden for Patients With Chronic Myeloid Leukemia Enrolled in Medicare Part D Taking Targeted Oral Anticancer Medications
PURPOSE: The number of targeted oral anticancer medications (TOAMs) has grown rapidly in the past decade. The high cost of TOAMs raises concerns about the financial aspect of treatment, especially for patients enrolled in Medicare Part D plans because of the coverage gap. METHODS: We identified pati...
Tallennettuna:
| Julkaisussa: | J Oncol Pract |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Clinical Oncology
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6366250/ https://ncbi.nlm.nih.gov/pubmed/28095170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.2016.014639 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|